New Key Statistics Module, Z-Score and F-Score
TSXV:CYTO Key Ratios
Market Cap C$ M | 24.19 |
Enterprise Value C$ M | 20.33 |
P/E(ttm) | 10.89 |
PE Ratio without NRI | 10.89 |
Forward PE Ratio | -- |
Price/Book | 4.85 |
Price/Sales | -- |
Price/Free Cash Flow | 13.61 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | 0.04 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 9.13 |
EV-to-EBITDA | 8.69 |
PEG | -- |
Shares Outstanding M | 53.75 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 111.45 |
Current Ratio | 111.45 |
ROA % (ttm) | 66.59 |
ROE % (ttm) | 70.05 |
ROIC % (ttm) | 198.13 |
Dividend Yield % | -- |
Altman Z-Score | -- |
TSXV:CYTO Number of Guru Trades
TSXV:CYTO Volume of Guru Trades
Gurus Latest Trades with TSXV:CYTO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:CYTO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cytophage Technologies Ltd Insider Transactions
No Available Data